Telix is at the forefront of theranostic drug development and is committed to improving the quality of life for people with cancer. We put patients at the heart of everything we do and currently have 33 clinical trials underway globally, including partnered IITs, spanning a range of diseases. See the graphic below for Telix-sponsored trials and select IITs.
Find out more about our active and completed clinical trials at ClinicalTrials.gov
